Clinical Trial Update: Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia [NA]

View source ↗

Summary

A clinical trial in Slovenia is evaluating immunotherapy efficacy and PD-L1 as a predictive biomarker for metastatic melanoma; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Metastatic Melanoma, Skin Cancer | NA | Status: RECRUITING